Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Most hepatitis A infections in recent years have been seen in people who use drugs and people experiencing homelessness.
Tight living spaces, lack of protective gear and preexisting health conditions may account for the higher death rate in prisons.
Telemedicine is increasingly in use during the COVID-19 pandemic.
This includes New York inmates who are older, sick, pregnant or have serious respiratory conditions or compromised immune systems.
The state will provide prisoners medication-assisted treatment to treat opioid use disorder and is creating more syringe services programs.
A Rhode Island study found that testing for hepatitis C among people on probation is likely a good way to find undiagnosed individuals.
But doing so would place a considerable financial burden on prison budgets.
Existing federal law could permit prisons to negotiate a 90 percent–plus discount—without scaring off pharma.
1 percent of the adult population is living with a chronic case of the virus.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
Compounding the problem, state prison systems do not have access to the drug discounts that certain federal agencies do.
Mass imprisonment of drug users worldwide, contributes to the spread of HIV, hepatitis B and C viruses and tuberculosis.
Mass imprisonment of drug users worldwide and insufficient harm reduction propel the spread of HIV, hepatitis B and C and tuberculosis.
Considering that more than 10 percent of Canadians with hepatitis C are incarcerated in any given year, the jails and prisons are excellent pl...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.